Pricing Log in Create free account
Saturday 17 October 2026 Export LLY’s income statement to Excel — free account

Eli Lilly and Company

LLY Healthcare Drug Manufacturers General

Eli Lilly and Company’s revenue for fiscal 2025 (year ended December 2025) was $65.2 billion, up 44.7% from fiscal 2024. In the quarter to June 2026, revenue grew 47.7%, EPS grew 26.2%, free cash flow grew 458.1% and total debt rose 37.6%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for five.

1,257.03 5.42 +0.43%
Market cap
$1.18T
P/E
42.2×
Fwd P/E
33.1×
Dividend yield
0.53%
F-score
7/9
Altman Z
8.61
Beneish M
−1.91
Dividend safety
86/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Eli Lilly and Company (LLY) Net margin

Alert me on Net margin

Eli Lilly and Company's net margin over the twelve months to 30 June 2026 was 33.5%, up 1.9 percentage points from fiscal 2025 (31.7%). Over the past ten years it has ranged from −1.02% (fiscal 2017) to 37.3% (fiscal 2019); the current reading is higher than 91% of that period. That is above the Drug Manufacturers General industry median of 8.27% and above the Healthcare sector median of 0.00%.

Net margin, annual

Embed this chart

Annual newest first

Period Net margin Change (points)
FY2025 31.7% 8.16
FY2024 23.5% 8.15
FY2023 15.4% (6.52)
FY2022 21.9% 2.17
FY2021 19.7% (5.53)
FY2020 25.2% (12.03)
FY2019 37.3% 22.23
FY2018 15.0% 16.06
FY2017 −1.02% (13.92)
FY2016 12.9% 0.83

Quarterly newest first

Period Net margin Change (points)
Jun 2026 30.9% (6.48)
Mar 2026 37.4% 2.95
Dec 2025 34.4% 2.69
Sep 2025 31.7% (4.67)
42 more quarters

Against its own ten years

Low −1.02% High 37.3%
Ten-year median 19.7%
Current reading's percentile 90

Net margin against peers

Company Net margin
LLY Eli Lilly and Company 33.5%
AMGN Amgen Inc. compare 23.0%
NVS Novartis AG compare 22.5%
AZN AstraZeneca PLC compare 17.0%
JNJ Johnson & Johnson compare 16.2%
ABBV AbbVie Inc. compare 9.74%
PFE Pfizer Inc. compare 6.80%
MRK Merck & Co., Inc. compare 4.77%
GILD Gilead Sciences, Inc. compare −10.6%
Drug Manufacturers General industry median 8.27%
Healthcare sector median 0.00%
Market median 0.45%

What Net margin is

Net Profit Margin tells an investor how much of each unit of revenue ends up as profit for shareholders after all costs, interest and taxes.

Net Income Allotted to Shareholders ÷ Revenue

The full definition of Net margin →

More on LLY